EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 347 filers reported holding EXELIXIS INC in Q4 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $163,000 | 0.0% | 9,240 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $163,000 | -76.6% | 9,240 | -71.7% | 0.00% | -80.0% |
Q2 2019 | $697,000 | +76.9% | 32,603 | +46.9% | 0.01% | +66.7% |
Q3 2018 | $394,000 | -17.6% | 22,200 | 0.0% | 0.00% | -25.0% |
Q2 2018 | $478,000 | -93.5% | 22,200 | -93.3% | 0.00% | -94.1% |
Q1 2018 | $7,329,000 | -52.0% | 330,866 | -34.1% | 0.07% | -47.7% |
Q4 2017 | $15,258,000 | +0.5% | 501,908 | -19.9% | 0.13% | -5.8% |
Q3 2017 | $15,181,000 | -45.2% | 626,520 | -44.3% | 0.14% | -48.5% |
Q2 2017 | $27,724,000 | +142.4% | 1,125,606 | +113.2% | 0.27% | +160.2% |
Q1 2017 | $11,439,000 | +34.0% | 527,871 | -7.8% | 0.10% | +21.2% |
Q4 2016 | $8,538,000 | – | 572,626 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |